conference on 3rd Annual Pharmacovigilance 2012 (3rd Annual Pharmacov)

Venue: Hyatt Regency, Mumbai, India

Location: Mumbai, Maharashtra, India

Event Date/Time: Aug 31, 2012 End Date/Time: Aug 31, 2012
Report as Spam


Conference on 3rd Annual Pharmacovigilance 2012 To be held on 31th Aug 2012 at Hyatt Regency, Mumbai, India


After the successful journey of 1st & 2nd Annual Pharmacovigilance 2010 & 2011, Virtue Insight is proud to announce its 3rd Annual Pharmacovigilance 2012 in India.

The Pharmaceutical industry in India is valued at Rs. 90,000 Crore and is growing at the rate of 12 – 14 % per annum. Exports are growing at 25 % Compound Annual Growth Rate (CAGR) every year. The total export of pharma products is to the extent of Rs. 40,000 Crore. India is now being recognized as the ‘Global pharmacy of Generic Drugs’ & has distinction of providing generic quality drugs at affordable cost. India is also emerging rapidly as a hub of Global Clinical trials & a destination for Drug Discovery & Development. Indian pharmaceutical industry is said to reach $20 billion by 2015, making it one of the world's top 10 pharmaceuticals markets. There is a surfeit of drug brands more than 6000 licensed drug manufactures & over 60,000 branded formulations. All medicines have potential risk as well as benefits.

In 2011 India exported USD 10.3 billion worth of pharma products, registering 17.5 per cent growth over a year before. India's largest export destination for pharma products is still the USA, followed by the UK, Germany, South Africa and Russia. By 2020, the size of the global pharmaceutical market is anticipated to grow to USD 1.3 trillion, with the E7 countries -- Brazil, China, India, Indonesia, Mexico, Russia and Turkey.


Exploiting the latest technologies, methodologies and Introducing pharmacy automations on work practices of Pharmacovigilance
Keeping abreast of the changes impacting the drug safety industry to ensure the pharmacovigilance strategies 0r robust & geared to compliance
Recent successful strategies and business models to bring out new medicines
How will PV activities change with Clinical Trial Transformation Initiative?
Identifying essential antidote requirements and learn to implement best practices in drug safety and surveillance
Exploiting the pharmacy automations and technologies for enhancement of medication safety
Stay ahead of computing and electronic communications in pharmacovigilance
Latest developments in pharmacovigilance, drug safety and risk management to ensure safer drugs to market
Establishing the importance of pharmacovigilance for the safety of the patient
Determining the steps and strategies for enhancing quality in healthcare
Improving patient care and safety in relation to use of medicines and all medical and paramedical interventions
Analyzing the information on current industry projects and trends
Identifying the latest regulatory framework for pharmacovigilance
Global marketing strategies in order to engage with regulatory centers of excellence on pharmacovigilance
Accelerating new medicine introduction in developing world & overcoming challenges
Explaining how to use the data sources and observational research for effective safety analysis
Good supply chain management practices for medicine distribution
Be part of a major networking opportunity
For more information kindly visit :


Contact us at :

Company Profiles And Conferences
Phone : + 91 22 27812707
Fax : + 91 22 27812290
E-mail :
Website :